 |
(1,3)-�-D-glucan synthesis inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Invasive Aspergillus infections |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-22 00:00:00 |
| Sponsor | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 |
| |
(1,3)-�-D-glucan synthesis inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Invasive Aspergillus infections |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-22 00:00:00 |
| Sponsor | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 |